Challenge-Enabled Machine Learning to Drug-Response Prediction
暂无分享,去创建一个
Yuanfang Guan | Hongyang Li | Ziyan Wang | Christopher Carpenter | Y. Guan | Hongyang Li | Ziyan Wang | C. Carpenter
[1] 黃崇冀,et al. Machine learning : an artificial intelligence approach , 1988 .
[2] Tapio Pahikkala,et al. Toward more realistic drug^target interaction predictions , 2014 .
[3] S. Rees,et al. Principles of early drug discovery , 2011, British journal of pharmacology.
[4] Tudor I. Oprea,et al. A comprehensive map of molecular drug targets , 2016, Nature Reviews Drug Discovery.
[5] John R. Anderson,et al. MACHINE LEARNING An Artificial Intelligence Approach , 2009 .
[6] Yuanfang Guan,et al. Machine Learning for Cancer Drug Combination , 2020, Clinical pharmacology and therapeutics.
[7] Bin Li,et al. Applications of machine learning in drug discovery and development , 2019, Nature Reviews Drug Discovery.
[8] Amir K. Foroushani,et al. Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen , 2019, Nature Communications.
[9] Yuanfang Guan,et al. TAIJI: approaching experimental replicates-level accuracy for drug synergy prediction , 2018, Bioinform..
[10] Guigang Zhang,et al. Deep Learning , 2016, Int. J. Semantic Comput..
[11] Sean Ekins. The Next Era: Deep Learning in Pharmaceutical Research , 2016, Pharmaceutical Research.
[12] Artem Cherkasov,et al. SimBoost: a read-across approach for predicting drug–target binding affinities using gradient boosting machines , 2017, Journal of Cheminformatics.
[13] Richard C. Mohs,et al. Drug discovery and development: Role of basic biological research , 2017, Alzheimer's & dementia.
[14] Thomas Blaschke,et al. The rise of deep learning in drug discovery. , 2018, Drug discovery today.
[15] Drews. Drug discovery today - and tomorrow. , 2000, Drug discovery today.
[16] Laura M. Heiser,et al. A community effort to assess and improve drug sensitivity prediction algorithms , 2014, Nature Biotechnology.
[17] Nci Dream Community. A community effort to assess and improve drug sensitivity prediction algorithms , 2014 .
[18] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[19] Xuefeng Wang,et al. Multiple-kernel learning for genomic data mining and prediction , 2018 .
[20] Radford M. Neal. Pattern Recognition and Machine Learning , 2007, Technometrics.
[21] Nello Cristianini,et al. Cross‐Validation (K‐Fold Cross‐Validation, Leave‐One‐Out, Jackknife, Bootstrap) , 2014 .
[22] Ethem Alpaydin,et al. Machine Learning: The New AI , 2016 .
[23] Yang Xie,et al. A community computational challenge to predict the activity of pairs of compounds Citation , 2015 .
[24] John P. Overington,et al. Comprehensive characterization of the Published Kinase Inhibitor Set , 2016, Nature Biotechnology.
[25] Bernard F. Buxton,et al. Drug Design by Machine Learning: Support Vector Machines for Pharmaceutical Data Analysis , 2001, Comput. Chem..
[26] Yuanfang Guan,et al. Network Propagation Predicts Drug Synergy in Cancers. , 2018, Cancer research.
[27] Daniel B. Mark,et al. TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .
[28] K. Borgwardt,et al. Machine Learning in Medicine , 2015, Mach. Learn. under Resour. Constraints Vol. 3.
[29] Arzucan Özgür,et al. DeepDTA: deep drug–target binding affinity prediction , 2018, Bioinform..